Showing results (91-100 of 377) with videos related to
Sort By:
Pageof 38
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 15, 2021
Exploring Racial Differences in Treatment Decision-making in Chinese Immigrant and White American Breast Cancer Patients: the Role of Patient-Provider CommunicationEllen R Huang, Joshua Longcoy, Jeannie Shen, et al.Hereditary Cancer in Clinical Practice|April 3, 2014
Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriersGillian W Hooker, Lesley King, Lauren Vanhusen, et al.JAMA Oncology|August 5, 2021
Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers: Review and Research RecommendationsJeanne S Mandelblatt, Tim A Ahles, Marc E Lippman, et al.Patient Education and Counseling|March 27, 2009
Evaluation of a virtual dialogue method for breast cancer patient educationWilliam G Harless, Marcia A Zier, Michael G Harless, et al.American Journal of Epidemiology|August 24, 2014
Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristicsRoni T Falk, Paige Maas, Catherine Schairer, et al.Journal of Surgical Oncology|April 30, 2020
Predictors of genetic testing uptake in newly diagnosed breast cancer patientsMary K Ladd, Beth N Peshkin, Claudine Isaacs, et al.Cancer Chemotherapy and Pharmacology|February 15, 2021
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancerFilipa Lynce, James T Williams, Meredith M Regan, et al.Gynecologic Oncology|July 7, 2009
Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriersDanielle Vicus, Barry Rosen, Jan Lubinski, et al.Journal of Cancer Survivorship : Research and Practice|October 21, 2016
Physical and psychological health in rare cancer survivorsNora K Horick, Adoma Manful, Jan Lowery, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 7, 2017
Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast CancerHuei-Ting Tsai, Claudine Isaacs, Filipa C Lynce, et al.Pageof 38